Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates-Reference-Cited by-同舟云学术

Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates

Published:2023-04 Issue:7 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

King Daniel A.¹^ORCID,Smith Amber R.²,Pineda Gino³^ORCID,Nakano Michitaka⁴^ORCID,Michelini Flavia⁵^ORCID,Goedegebuure S. Peter⁶,Thyparambil Sheeno⁷,Liao Wei-Li⁷,McCormick Aaron⁴,Ju Jihang⁴,Cioffi Michele⁸^ORCID,Zhang Xiuli⁶,Hundal Jasreet⁶,Griffith Malachi⁹^ORCID,Grandori Carla¹⁰,Pollastro Maddy¹⁰,Rosati Rachele¹⁰,Margossian Astrid¹⁰,Chatterjee Payel¹⁰,Ainge Trevor¹⁰,Flory Marta¹¹,Ocampo Paolo¹²,Chen Lee-may¹³,Poultsides George A.¹⁴,Baron Ari D.¹⁵,Chang Daniel T.¹⁶^ORCID,Herman Joseph M.¹⁷,Gillanders William E.⁶,Park Haeseong¹⁸^ORCID,Hoos William A.¹⁹,Nichols Mike²⁰,Fisher George A.³^ORCID,Kuo Calvin J.³^ORCID

Affiliation:

1. Northwell Health Cancer Institute and Feinstein Institute of Research, Lake Success, NY

2. Xilis Corporation, Durham, NC

3. Stanford Cancer Institute, Stanford, CA

4. Department of Medicine, Divisions of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA

5. Memorial Sloan Kettering Cancer Center, NY, NY

6. Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO

7. Mprobe, Inc, Rockville, MD

8. Cornell University, School of Medicine, New York, NY

9. Department of Medicine, Washington University School of Medicine, St Louis, MO

10. SEngine Precision Medicine, Seattle, WA

11. Department of Radiology, Stanford University, Stanford, CA

12. Personalized Healthcare, Genentech, Inc, South San Francisco, CA

13. Department of Gynecologic Oncology, University of California at San Francisco, San Francisco, CA

14. Department of Surgery, Section of Surgical Oncology, Stanford University, Stanford, CA

15. Division of Hematology Oncology, California Pacific Medical Center, San Francisco, CA

16. Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA

17. Department of Radiation Oncology and Northwell Health Cancer Institute, Lake Success, NY

18. Department of Medicine, Division of Oncology, Washington University School of Medicine in St Louis

19. xCures Inc, Oakland, CA

20. Independent Clinician, Saratoga, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.21.00489

Reference38 articles.

1. Assessment of a HER2 scoring system for gastric cancer: results from a validation study

2. Clinical and molecular characterization of HER2 amplified-pancreatic cancer

3. Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)

4. Antitumor Effect of Trastuzumab for Pancreatic Cancer with High HER-2 Expression and Enhancement of Effect by Combined Therapy with Gemcitabine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostic nanoparticles for detection and treatment of pancreatic cancer;WIREs Nanomedicine and Nanobiotechnology;2024-07

2. Quantitative proteomic analysis of HER2 protein expression in PDAC tumors;Clinical Proteomics;2024-03-20

3. ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition;Frontiers in Oncology;2024-02-08

4. Tetrahydrobenzothiophene derivatives ameliorate Mia PaCa-2 cell progression and induces apoptosis via inhibiting EGFR2 tyrosine kinase signal;Bioorganic Chemistry;2024-02

5. The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma;Cancers;2024-01-28